KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $32.03 $45.00 Friday, 26th Apr 2024 CRBP stock ended at $34.25. This is 2.24% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 7.30% from a day low at $32.27 to a day high of $34.63.
90 days $17.66 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Apr 26, 2024 $33.33 $34.63 $32.27 $34.25 90 155
Apr 25, 2024 $34.51 $35.09 $32.03 $33.50 142 138
Apr 24, 2024 $37.97 $38.34 $34.24 $35.54 219 990
Apr 23, 2024 $37.83 $40.08 $37.66 $37.74 500 508
Apr 22, 2024 $38.73 $39.94 $36.84 $37.70 92 214
Apr 19, 2024 $35.79 $39.86 $35.79 $39.24 278 002
Apr 18, 2024 $36.17 $37.78 $35.26 $36.53 127 788
Apr 17, 2024 $41.12 $41.12 $36.09 $37.16 417 654
Apr 16, 2024 $42.71 $45.00 $40.96 $41.12 351 751
Apr 15, 2024 $40.68 $42.96 $39.58 $42.72 334 150
Apr 12, 2024 $39.65 $40.99 $39.17 $40.85 291 611
Apr 11, 2024 $38.10 $40.15 $37.00 $40.00 186 323
Apr 10, 2024 $36.03 $38.56 $35.50 $38.15 65 871
Apr 09, 2024 $40.33 $40.89 $36.01 $37.47 222 997
Apr 08, 2024 $40.06 $42.20 $37.50 $40.16 205 880
Apr 05, 2024 $39.62 $40.35 $38.81 $39.97 151 138
Apr 04, 2024 $39.59 $40.67 $38.77 $38.97 161 276
Apr 03, 2024 $37.01 $40.29 $37.01 $38.50 194 749
Apr 02, 2024 $37.21 $40.64 $35.80 $37.46 213 679
Apr 01, 2024 $39.24 $40.94 $37.99 $37.99 172 706
Mar 28, 2024 $35.42 $39.96 $35.16 $39.24 234 856
Mar 27, 2024 $36.03 $36.53 $33.24 $35.57 173 999
Mar 26, 2024 $35.42 $38.24 $35.34 $36.15 239 511
Mar 25, 2024 $35.80 $36.56 $35.00 $35.63 235 828
Mar 22, 2024 $37.02 $38.00 $34.44 $34.94 184 862
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT